Evaluation of the efficacy of celecoxib in the treatment of acute mania

Phase 2

• Conditions: mania.; Bipolar disorder, current episode manic without psychotic features; F31.1

• Registration Number: IRCT20200306046708N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 April 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Eligible for Mania Course based on DSM IV - TR Diagnostic Criteria
No other supportive therapy or use of cognitive therapy.
Age between 18 and 65 years.
Fill out the informed consent form.

Exclusion Criteria

Causing side effects.
Willingness to exit the study
Unavailability of the patient.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mania. Timepoint: baseline, 4, 8, 12 weeks. Method of measurement: young questionnaire.